loaderimg
image

Founded in December 2012, Swiss Medendi SA developed a proprietary technology for the intravenous (IV) administration of vesicant and irritant drugs. This technology permits a safe chemotherapy infusion via peripheral venous access devices, therefore it protects the patient’s blood vessels from chemical phlebitis and increases the patient’s quality of life. This technology further creates significant cost saving to hospitals and other medical providers.
The Swiss Medendi solution offers the safest and most cost effective means for IV infusion of vesicant and irritant drugs minimizing adverse side effects, risks and injuries. Further it results in providing better treatment to the patient by eliminating unnecessary procedures, such as placement of central line (CL) supporting catheter reducing initiatives when the risks exceed their benefits.

Company’s Keywords:

Q How Many Employees Does This Company Have?

<1

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2012

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image